Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated death globally. Liver transplantation (LT) has emerged as a key treatment for patients with HCC, and the Milan criteria have been adopted as the cornerstone of the selection policy. To allow more patients to benefit from LT, a number of expanded criteria have been proposed, many of which use radiologic morphological characteristics with larger and more tumors as surrogates to predict outcomes. Other groups developed indices incorporating biological variables and dynamic markers of response to locoregional treatment. These expanded selection criteria achieved satisfactory results with limited liver supplies. In addition, a number of prognostic models have been developed using clinicopathological characteristics, imaging radiomics features, genetic data, and advanced techniques such as artificial intelligence. These models could improve prognostic estimation, establish surveillance strategies, and bolster long-term outcomes in patients with HCC. In this study, we reviewed the latest findings and achievements regarding the selection criteria and post-transplant prognostic models for LT in patients with HCC.
Citations
Citations to this article as recorded by
A systematic review of MicroRNA (miRNA) biomarkers in the diagnosis and prognosis of hepatocellular carcinoma J. M. John Britto, T Beula Bell Irish Journal of Medical Science (1971 -).2026; 195(2): 1051. CrossRef
Correspondence to editorial on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma” Soon Sun Kim, Hyung Seok Kim, Jae Youn Cheong, Jung Woo Eun Clinical and Molecular Hepatology.2026; 32(1): e72. CrossRef
Artificial Intelligence Applications in the Diagnosis, Treatment, and Prognosis of Hepatocellular Carcinoma Ming-Ying Lu, Jacky Chung-Hao Wu, Henry Horng-Shing Lu, Mohammed Eslam, Ming-Lung Yu Gut and Liver.2026; 20(1): 5. CrossRef
Liver Transplantation Following Immune Checkpoint Inhibitor Therapy: What Do We Need to Know from Clinical and Immunological Perspective? Hee Sun Cho, Soon Kyu Lee International Journal of Molecular Sciences.2026; 27(6): 2680. CrossRef
Bibliometric analysis of application of radiomics and artificial intelligence integration in personalized treatment of hepatocellular carcinoma Zhujuan Yu, Li Ke, Zhifeng Lin International Journal of Surgery.2026; 112(3): 8095. CrossRef
SREBP2 as a Novel Biomarker for Posttransplant Hepatocellular Carcinoma Recurrence: A New Prognostic Nomogram Jiali Qiu, Lei Cao, Sensheng Bi, Pengyu Han, Zhenglu Wang, Yoel A. Klug BioMed Research International.2026;[Epub] CrossRef
Hepatocellular carcinoma: current aspects of multidisciplinary management. Part 2. Treatment and prevention Yu.M. Stepanov, N.Yu. Zavhorodnia, O.M. Vlasova GASTROENTEROLOGY.2026; 60(1): 52. CrossRef
Redefining Liver Transplantation Indications for Hepatic Malignancies in the Era of Precision Transplant Oncology: An Up-to-Date Narrative Review Mario Romeo, Fiammetta Di Nardo, Carmine Napolitano, Paolo Vaia, Claudio Basile, Giusy Senese, Annachiara Coppola, Patrizia Iodice, Simone Olivieri, Alessandro Federico, Marcello Dallio Journal of Clinical Medicine.2026; 15(10): 3579. CrossRef
Liver Transplantation in the Era of Artificial Intelligence: Surgical Innovation, Risk Stratification, and Patient-centred Care Aditi Naidu Patti, Vinod Kumar Mugada, Devika Boddu, Benarjee Veera Mani Kishore Boddeda, Srinivasa Rao Yarguntla Prague Medical Report.2026; 127(2): 69. CrossRef
Comparative analysis of post-transplant mortality and morbidity rates in groups within and beyond the Milan criteria for hepatocellular carcinoma Muzaffer Atlı, Süleyman Koç Cukurova Medical Journal.2026; 51(2): 519. CrossRef
Review Article: Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine Yule Ma, Huigang Li, Huan Chen, Jinxin Xu, Ziyi Ye, Yuhang Li, Xiang Wu, Jinyan Chen, Chenghao Cao, Peiru Zhang, Ruijie Zhao, Jun Li, Cheng Zhu, Jianyong Zhuo, Shengjun Xu, Xiao Xu, Di Lu Alimentary Pharmacology & Therapeutics.2026; 64(4): 441. CrossRef
Improving the choice of liver transplant for hepatocellular carcinoma: Editorial on “Network meta-analysis and validation study of expanded liver transplantation criteria for hepatocellular carcinoma: Significant role of alpha-fetoprotein” Jongman Kim Clinical and Molecular Hepatology.2026; 32(3): 1461. CrossRef
Current strategies in managing metabolic complications following liver transplantation Soon Kyu Lee Annals of Liver Transplantation.2025; 5(1): 3. CrossRef
Artificial intelligence in gastrointestinal surgery: A minireview of predictive models and clinical applications Himanshu Agrawal, Nikhil Gupta, Himanshu Tanwar, Natasha Panesar Artificial Intelligence in Gastroenterology.2025;[Epub] CrossRef
Machine Learning–Based Selection of Resection vs Transplant and Survival in Hepatocellular Carcinoma Hyun Uk Kim, Ji Won Han, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Ho Joong Choi, Young Kyoung You JAMA Network Open.2025; 8(9): e2532353. CrossRef
Prognostic Significance of Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Liver Transplantation for Hepatocellular Carcinoma Imam Bakir Bati, Umut Tuysuz, Elif Eygi Current Oncology.2025; 32(8): 464. CrossRef
Advancing Hepatocellular Carcinoma Therapy with Next-Generation Molecular and Immunotherapeutics Mudassir Hassan, Ijaz Hussain, Kafeel Ahmad, Saima Zafar, Adeel Khalid, Muhammad Haseeb, Nazim Hussain, Muhammad Adeel Ghafar Journal of Hepatocellular Carcinoma.2025; Volume 12: 2907. CrossRef
Liver transplantation for alcohol-related liver disease in Korea: The need for patient management guidelines Soon Kyu Lee Annals of Liver Transplantation.2024; 4(2): 40. CrossRef
First
Prev
